Millendo Therapeutics Appoints Acceleron CEO Habib Dable to its Board of Directors September 25, 2018
Verastem Oncology Signs Exclusive License Agreement for the Development and Commercialization of COPIKTRA™ (duvelisib) in China September 25, 2018
Longwood-Founded Verastem Oncology Receives FDA Approval of COPIKTRA™ (duvelisib) Capsules September 24, 2018
Millendo Announces Initiation of Phase 2b Clinical Trial of Nevanimibe in Patients with Classic CAH September 13, 2018
